Clinical Trials Sponsored by The First People's Hospital of Tongxiang City

Total 954 results

Second Affiliated Hospital, School of Medicine,...
The First People's Hospital of Huzhou; The Central Hospital of Lishui City; Taizhou... and other collaborators

Completed

Ginkgolide With Intravenous Alteplase Thrombolysis in Acute Ischemic Stroke Neurological Improving Trial (GIANT)

Intravenous Alteplase Thrombolysis | Neurological Improving

China
The First Hospital of Jilin University
Liaoyuan City Central Hospital; SIPING FIRST PEOPLE'S HOSPITAL

Active, not recruiting

Preoperative Prediction of Adherent Perirenal Fat. (APF)

Radiomics

China
The First People's Hospital of Changzhou

Not yet recruiting

SBRT Combined With AK104 to Treatment Relapsed or Metastatic ESCC

Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
The First People's Hospital of Lianyungang

Recruiting

Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC

Lung Neoplasms

China
The First People's Hospital of Jingzhou

Recruiting

Early Arthroscopic Partial Meniscectomy(APM)

Meniscus Tear

China
The First People's Hospital of Changzhou

Not yet recruiting

Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin
The First People's Hospital of Changzhou

Not yet recruiting

Effect of Cytokine-induced Killer Cells for Advanced Malignant Gliomas

Cytokine-Induced Killer Cells | Advanced Milignant Gliomas
The First People's Hospital of Changzhou

Active, not recruiting

The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal Cancer

Colorectal Neoplasms
The First People's Hospital of Changzhou

Active, not recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma

Ovarian Carcinoma
The First People's Hospital of Changzhou

Active, not recruiting

Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer

Breast Cancer
The First People's Hospital of Changzhou

Active, not recruiting

CIK in Treating Patients With Bladder Cancer

Urinary Bladder Neoplasms
The First People's Hospital of Changzhou

Not yet recruiting

Cytokine-induced Killer Study for Patients With Stage II Melanoma

Melanoma
The First People's Hospital of Changzhou

Not yet recruiting

Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas

Cytokine-Induced Killer Cells | Milignant Gliomas
The First People's Hospital of Changzhou

Not yet recruiting

CIK in Treating Patients With Esophageal Cancer

Esophageal Squamous Cell Carcinoma
The First People's Hospital of Changzhou

Not yet recruiting

DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating

Renal Neoplasma
The First People's Hospital of Huzhou

Completed

Clinical Analysis of Vitamin B6 in Sepsis

Sepsis | Inflammatory Response | Kidney Injury | Vitamin B6 | Oxidative Stress Response

China
The First People's Hospital of Huzhou

Completed

Three-level Network Rehabilitation Model

Stroke | Primary Medical Care

China
The First People's Hospital of Jingzhou

Completed

Metabolic Syndrome and Degenerative Meniscus Lesions Related Knee Function

Metabolic Syndrome | Knee Arthritis | Obesity, Abdominal | Meniscus Lesion

China
The First People's Hospital of Changzhou

Active, not recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma

Cholangiocarcinoma

China
The First People's Hospital of Changzhou

Completed

Microwave Ablation for Pulmonary Metastases From Colorectal Cancer

Colorectal Cancer
The First People's Hospital of Changzhou

Active, not recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer

Cervical Cancer
The First People's Hospital of Changzhou

Active, not recruiting

Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer

Gastric Cancer
The First People's Hospital of Changzhou

Active, not recruiting

The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer

Stomach Neoplasms
The First People's Hospital of Changzhou

Completed

Hepatic RFA Increases T Cell Infiltraion and PD-L1 Expression in Primary Colorecatl Cancer

Colorectal Cancer
The First People's Hospital of Changzhou

Completed

TOF Versus SOX in Metastatic Gastric Cancer

Gastric Cancer
The First People's Hospital of Changzhou

Completed

Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer

Rectum Cancer
The First People's Hospital of Changzhou

Completed

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases

Colorectal Cancer

China
The First People's Hospital of Lianyungang

Not yet recruiting

B7-H3 Targeting CAR-T Cells Therapy for B7-H3 Positive Solid Tumors

Advanced Solid Tumor

China
The First People's Hospital of Jingzhou

Completed

Calorie Restricted Diet and Exercise

Metabolic Syndrome

China
The First People's Hospital of Zunyi

Completed

Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal Failure Hemodialysis Patients

Hemodialysis | Chronic Renal Failure

China
The First People's Hospital of Jingzhou

Completed

Metabolic Syndrome and Degenerate Meniscus Tears

Metabolic Syndrome | Meniscus; Degeneration

China
The First People's Hospital of Jingzhou

Completed

Clinical Study on the Treatment of Hypertensive Intracerebral Hemorrhage With Panax Notoginseng Saponin (CSTHIHPNS)

Hematoma Absorption and Neurological Function Recovery
The First People's Hospital of Changzhou

Unknown

SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer

Colorectal Neoplasm

China
The First People's Hospital of Changzhou

Active, not recruiting

The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR

Adenocarcinoma of Lung
Huai'an First People's Hospital
Zhenjiang First People's Hospital; The Affiliated Hospital of Xuzhou Medical... and other collaborators

Recruiting

Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA.

Acute Myeloid Leukemia

China
jiangjingting

Unknown

Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma

Lymphoma, B Cell

China
The First People's Hospital of Yuhang District

Completed

Gastric Outlet Obstructions Tailored Covered Stents for GOO

Gastric Outlet Obstruction

China
chenwu

Recruiting

Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer

Gastric Cancer | Circulating Tumor DNA (ctDNA)

China
Shandong University
The People's Hospital of Zhaoyuan City; Shanghe People's Hospital

Recruiting

Fecal Immunochemical Test for Advanced Adenoma Detection in Colorectal Cancer Screening

Colorectal Neoplasms | Colorectal Cancer | Colorectal Adenoma

China
The First Affiliated Hospital of Soochow University
Second Affiliated Hospital of Soochow University; The Second People's Hospital... and other collaborators

Unknown

Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients

Acute Myeloid Leukemia | Induction Chemotherapy

China
The First Affiliated Hospital of Soochow University
Second Affiliated Hospital of Soochow University; The Second People's Hospital... and other collaborators

Unknown

Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60

Acute Myeloid Leukemia | Induction Chemotherapy

China
The First People's Hospital of Lianyungang
The East Hospital of Lianyungang; Donghai People's Hospital; People's Hospital...

Unknown

A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal Cancer

Inoperable Esophageal Cancer Stage I-III

China
The First Affiliated Hospital with Nanjing Medical...
Zhenjiang First People's Hospital; Second Affiliated Hospital of Soochow University and other collaborators

Not yet recruiting

A Clinical Study of the Value of Circulating Free Methylated EBV DNA in Extranodal NK/T Cell Lymphoma

Extranodal Natural Killer/T-cell Lymphoma

China
Hepatopancreatobiliary Surgery Institute of Gansu...
The First Affiliated Hospital of Anhui Medical University; LanZhou University; Beijing YouAn Hospital and other collaborators

Completed

Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)

COVID-19 | Vaccine Reaction | Liver Disease

China
Wu Jun

Not yet recruiting

Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction，a Phase II Clinical Study

Adenocarcinoma | Gastric Cancer | GastroEsophageal Cancer

China
Yang Chaonan

Not yet recruiting

Construction and Application of Pressure Injury Risk Prediction Model for Critically Ill Patients

Risk Factors | Critically Ill Patients | Pressure Injury | Machine Learning Algorithms
JUNYAN ZHANG
The First People's Hospital of Xuzhou

Unknown

25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China (RaTAPDR)

Proliferative Diabetic Retinopathy

China
Hu Hao

Unknown

Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism

Hyperthyroidism

China
JUNYAN ZHANG
The First People's Hospital of Xuzhou

Unknown

25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial (aiRTo-PDR)

Proliferative Diabetic Retinopathy

China
Wu Jun

Recruiting

Efficacy and Safety of Fruquintinib in Combination With PD-1 Inhibitors as First-line Maintenance Therapy for Advanced HER-2 Negative Gastric Cancer: a Single-arm, Prospective, Exploratory Clinical Study

Gastric Cancer

China

Clinical Trials Sponsored by The First People's Hospital of Tongxiang City

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations